A RIPK1-specific PROTAC degrader achieves potent antitumor activity by enhancing immunogenic cell death is a research paper published in Immunity (2024). On theSindex it has a DataRank of 0. It has been cited 85 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Breast Cancer Now
Grant: CTR-QR14-007
CRUK
Grant: C26866/A24399
CRUK
Grant: CRM089X
Manchester Biomedical Research Centre
Grant: -6
Manchester Biomedical Research Centre
Grant: -7
NIH
Grant: R21-R21AI175590
Cancer Research UK
Grant: S_4256
LEO Foundation Skin Immunology Research Center
Grant: Mol Immunology and Inflammation
NIAID NIH HHS
Grant: R21 AI175590
Cancer Research UK
Fields of Study
MeSH Terms
Keywords